AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

FEBUXOSTAT 80.000 Mg ;

12 registrations across 1 African market— 12 active

Markets with FEBUXOSTAT 80.000 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
ANDOURISTAT 80 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
DONIFOXATE 80 mg
Film Coated Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Xanthibux
Film Coated Tablets
🇪🇬EgyptMedizen pharmaceutical industries (Medizen)active
DONIFOXATE 80 mg
Film Coated Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
ANDOURISTAT 80 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Xanthibux
Film Coated Tablets
🇪🇬EgyptMedizen pharmaceutical industries (Medizen)active
Uricodrop 80mg
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Xanthistop 80 mg
Film Coated Tablets
🇪🇬EgyptInspire Pharmaceutical Company IPC Pharmaactive
Febumagictam
Film Coated Tablets
🇪🇬EgyptMagic Pharmaactive
Febumagictam
Film Coated Tablets
🇪🇬EgyptMagic Pharmaactive
Uricodrop 80mg
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Staturic 80 mg
Film Coated Tablets
🇪🇬EgyptBio Med For Pharmaceutical Industries (BIOMED)active

FEBUXOSTAT 80.000 Mg ; in Africa — Regulatory Overview

FEBUXOSTAT 80.000 Mg ; is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.